Agreement Between Pleth Variability Index and Arterial Pulse Pressure Variation During Gynecological Laparoscopic Surgery

November 15, 2026 updated by: İlke Dolgun, Istinye University

The Effect of Stepwise Trendelenburg Positioning and Pneumoperitoneum on the Agreement Between Pleth Variability Index (PVi) and Manually Calculated Invasive Pulse Pressure Variation (PPV) During Gynecological Laparoscopic Surgery: A Prospective Observational Study

This prospective observational study aims to evaluate the agreement between the non-invasive Pleth Variability Index (PVi) and manually calculated invasive Pulse Pressure Variation (PPV) during gynecological laparoscopic surgery. Measurements will be obtained at five predefined intraoperative time points corresponding to baseline supine positioning, pneumoperitoneum, 15-degree Trendelenburg positioning, 30-degree Trendelenburg positioning, and return to the supine position after desufflation. The study will assess changes in the relationship and agreement between these two hemodynamic parameters under different surgical conditions.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Merkez Mahallesi
      • Istanbul, Merkez Mahallesi, Turkey (Türkiye), 34250
        • Istinye Üniversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of 45 female patients aged 18-65 years with ASA physical status I-III who are scheduled to undergo elective gynecological laparoscopic surgery, including hysterectomy, myomectomy, and gynecological oncological procedures. All participants will have clinically indicated invasive arterial monitoring, sinus rhythm, and mechanical ventilation with a fixed tidal volume of 8 mL/kg of ideal body weight. Patients meeting the predefined inclusion and exclusion criteria will be enrolled in this prospective observational study.

Description

Inclusion Criteria:

  • Female patients aged 18-65 years.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Scheduled for elective gynecological laparoscopic surgery, including hysterectomy, myomectomy, or gynecological oncological surgery.
  • Clinically indicated invasive arterial monitoring during surgery.
  • Sinus rhythm without clinically significant arrhythmias.
  • Mechanical ventilation with a fixed tidal volume of 8 mL/kg of ideal body weight.

Exclusion Criteria:

  • Atrial fibrillation or frequent supraventricular or ventricular premature contractions.
  • Severe peripheral arterial disease or Raynaud phenomenon.
  • History of open-heart surgery or severe valvular heart disease, particularly aortic regurgitation.
  • Increased intracranial pressure syndrome.
  • Pulmonary pathology requiring a tidal volume below 8 mL/kg.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement Between Pleth Variability Index (PVi) and Manually Calculated Invasive Pulse Pressure Variation (PPV)
Time Frame: Intraoperatively, 5 minutes after establishment of each predefined condition at T1, T2, T3, and T4.

Correlation coefficients and Bland-Altman bias and 95% limits of agreement between PVi and manually calculated invasive PPV will be evaluated at four intraoperative conditions: baseline supine position (T1), pneumoperitoneum in supine position (T2), pneumoperitoneum with 15-degree Trendelenburg positioning (T3), and pneumoperitoneum with 30-degree Trendelenburg positioning (T4).

Intraoperatively, 5 minutes after establishment of each predefined condition at T1, T2, T3, and T4.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 21, 2026

Primary Completion (Estimated)

February 21, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

November 15, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HASEKI-PVI-PPV-2026 MASSIMO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe